Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine
- PMID: 18378801
- DOI: 10.1124/jpet.107.133413
Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine
Abstract
Voltage-gated sodium channels play a critical role in excitability of nociceptors (pain-sensing neurons). Several different sodium channels are thought to be potential targets for pain therapeutics, including Na(v)1.7, which is highly expressed in nociceptors and plays crucial roles in human pain and hereditary painful neuropathies, Na(v)1.3, which is up-regulated in sensory neurons following chronic inflammation and nerve injury, and Na(v)1.8, which has been implicated in inflammatory and neuropathic pain mechanisms. We compared the effects of lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], a new pain therapeutic, with those of lidocaine and carbamazepine on recombinant Na(v)1.7 and Na(v)1.3 currents and neuronal tetrodotoxin-resistant (Na(v)1.8-type) sodium currents using whole-cell patch-clamp electrophysiology. Lacosamide is able to substantially reduce all three current types. However, in contrast to lidocaine and carbamazepine, 1 mM lacosamide did not alter steady-state fast inactivation. Inhibition by lacosamide exhibited substantially slower kinetics, consistent with the proposal that lacosamide interacts with slow-inactivated sodium channels. The estimated IC(50) values for inhibition by lacosamide of Na(v)1.7-, Na(v)1.3-, and Na(v)1.8-type channels following prolonged inactivation were 182, 415, and 16 microM, respectively. Na(v)1.7-, Na(v)1.3-, and Na(v)1.8-type channels in the resting state were 221-, 123-, and 257-fold less sensitive, respectively, to lacosamide than inactivated channels. Interestingly, the ratios of resting to inactivated IC(50)s for carbamazepine and lidocaine were much smaller (ranging from 3 to 16). This suggests that lacosamide should be more effective than carbamazepine and lidocaine at selectively blocking the electrical activity of neurons that are chronically depolarized compared with those at more normal resting potentials.
Similar articles
-
Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation.J Neurosci Res. 2013 Mar;91(3):436-43. doi: 10.1002/jnr.23136. Epub 2012 Dec 13. J Neurosci Res. 2013. PMID: 23239147
-
Use-dependent block by lidocaine but not amitriptyline is more pronounced in tetrodotoxin (TTX)-Resistant Nav1.8 than in TTX-sensitive Na+ channels.J Pharmacol Exp Ther. 2007 Jan;320(1):354-64. doi: 10.1124/jpet.106.109025. Epub 2006 Sep 27. J Pharmacol Exp Ther. 2007. PMID: 17005919
-
Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States.Mol Pharmacol. 2017 Apr;91(4):277-286. doi: 10.1124/mol.116.106401. Epub 2017 Jan 24. Mol Pharmacol. 2017. PMID: 28119481 Free PMC article.
-
The role of voltage-gated sodium channels in neuropathic pain.Curr Opin Neurobiol. 2003 Jun;13(3):291-7. doi: 10.1016/s0959-4388(03)00074-6. Curr Opin Neurobiol. 2003. PMID: 12850213 Review.
-
The roles of sodium channels in nociception: Implications for mechanisms of pain.Pain. 2007 Oct;131(3):243-257. doi: 10.1016/j.pain.2007.07.026. Epub 2007 Sep 4. Pain. 2007. PMID: 17766042 Free PMC article. Review.
Cited by
-
Discovery of the First Orally Available, Selective KNa1.1 Inhibitor: In Vitro and In Vivo Activity of an Oxadiazole Series.ACS Med Chem Lett. 2021 Mar 9;12(4):593-602. doi: 10.1021/acsmedchemlett.0c00675. eCollection 2021 Apr 8. ACS Med Chem Lett. 2021. PMID: 33859800 Free PMC article.
-
Fenestrations control resting-state block of a voltage-gated sodium channel.Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13111-13116. doi: 10.1073/pnas.1814928115. Epub 2018 Dec 5. Proc Natl Acad Sci U S A. 2018. PMID: 30518562 Free PMC article.
-
Inhibition of neuronal voltage-gated sodium channels by brilliant blue G.Mol Pharmacol. 2011 Aug;80(2):247-57. doi: 10.1124/mol.110.070276. Epub 2011 May 2. Mol Pharmacol. 2011. PMID: 21536754 Free PMC article.
-
Sidedness of carbamazepine accessibility to voltage-gated sodium channels.Mol Pharmacol. 2014 Feb;85(2):381-7. doi: 10.1124/mol.113.090472. Epub 2013 Dec 6. Mol Pharmacol. 2014. PMID: 24319110 Free PMC article.
-
Distinct impacts of sodium channel blockers on the strength-duration properties of human motor cortex neurons.Epilepsia. 2025 Jul 7:10.1111/epi.18540. doi: 10.1111/epi.18540. Online ahead of print. Epilepsia. 2025. PMID: 40622689
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases